Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm?
- PMID: 22873119
- PMCID: PMC3508868
- DOI: 10.1186/1750-9378-7-18
Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm?
Abstract
The regulation of cancerous tumor development is converged upon by multiple pathways and factors. Besides environmental factors, gastrointestinal (GI) tract cancer can be caused by chronic inflammation, which is generally induced by bacteria, viruses, and parasites. The role of these inducers in cancer development, cell differentiation and transformation, cell cycle deregulation, and in the expression of tumor-associated genes cannot be ignored. Although Helicobacter pylori activates many oncogenic pathways, particularly those in gastric and colorectal cancers, the role of viruses in tumor development is also significant. Viruses possess significant oncogenic potential to interfere with normal cell cycle control and genome stability, stimulating the growth of deregulated cells. An increasing amount of recent data also implies the association of GI cancers with bacterial colonization and viruses. This review focuses on host-cell interactions that facilitate primary mechanisms of tumorigenesis and provides new insights into novel GI cancer treatments.
Similar articles
-
Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses.J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S191-S196. doi: 10.1097/MCG.0000000000000714. J Clin Gastroenterol. 2016. PMID: 27741173 Review.
-
The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.Front Cell Infect Microbiol. 2012 Jan 3;1:21. doi: 10.3389/fcimb.2011.00021. eCollection 2011. Front Cell Infect Microbiol. 2012. PMID: 22919587 Free PMC article. Review.
-
The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances.Front Immunol. 2020 Jun 30;11:1387. doi: 10.3389/fimmu.2020.01387. eCollection 2020. Front Immunol. 2020. PMID: 32695120 Free PMC article. Review.
-
The Role of Gut Microbiota in Gastrointestinal Tract Cancers.Arch Immunol Ther Exp (Warsz). 2022 Feb 3;70(1):7. doi: 10.1007/s00005-021-00641-6. Arch Immunol Ther Exp (Warsz). 2022. PMID: 35112169 Free PMC article. Review.
-
Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit-risk approach?World J Gastroenterol. 2022 Feb 21;28(7):766-774. doi: 10.3748/wjg.v28.i7.766. World J Gastroenterol. 2022. PMID: 35317277 Free PMC article.
Cited by
-
Prolonged inflammatory microenvironment is crucial for pro-neoplastic growth and genome instability: a detailed review.Inflamm Res. 2017 Feb;66(2):119-128. doi: 10.1007/s00011-016-0985-3. Epub 2016 Sep 21. Inflamm Res. 2017. PMID: 27653961 Review.
-
Weight change therapy as a potential treatment for end-stage ovarian carcinoma.Am J Case Rep. 2014 May 12;15:203-11. doi: 10.12659/AJCR.890229. eCollection 2014. Am J Case Rep. 2014. PMID: 24847411 Free PMC article.
-
Role of viruses in the development of breast cancer.Infect Agent Cancer. 2013 Sep 2;8:32. doi: 10.1186/1750-9378-8-32. eCollection 2013. Infect Agent Cancer. 2013. PMID: 24138789 Free PMC article. Review.
-
Case-control study of metabolic syndrome and ovarian cancer in Chinese population.Nutr Metab (Lond). 2017 Feb 28;14:21. doi: 10.1186/s12986-017-0176-4. eCollection 2017. Nutr Metab (Lond). 2017. PMID: 28261315 Free PMC article.
-
Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines.BMC Complement Med Ther. 2024 Apr 30;24(1):178. doi: 10.1186/s12906-024-04479-1. BMC Complement Med Ther. 2024. PMID: 38689275 Free PMC article.
References
-
- Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–592. - PubMed
LinkOut - more resources
Full Text Sources